&quot;Metabolism and Response to Stress&quot; (MARS) gene signatures reveal heterogeneity in patients with Ulcerative Colitis and identify characteristics of patients with increased response to therapy

andecaliximab (GS-5745) - Gilead

Stelara (ustekinumab) - J&J

B. Linggi1; B. Sangiorgi1; M.I. Smith1; W. Teft1; V. Jairath1,2,3; C. Ma1,4,5; N. Vande Casteele1,6.

Jan 26, 2024